Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequence of Aldesleukin and Ipilimumab in Metastatic Melanoma
NCT01856023Phase 4Terminated
- Sponsor
- Clinigen
- Start
- May 2013
- Primary completion
- Jul 2015
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of aldesleukin in melanoma, sponsored by Clinigen. Started May 2013; status: terminated.
02
Drugs
aldesleukin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01856023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856023.